Syrrx, Inc. Announces Research Collaboration With Biogen Idec, Inc. (Massachusetts) (BIIB) And Receives First Success Payment
10/19/2005 5:11:32 PM
Syrrx, Inc., a next generation structure based drug discovery company, today announced the receipt of the first success-based milestone payment from Biogen Idec (NASDAQ:BIIB) based on a collaborative agreement executed on December 16, 2003 between the two parties. The collaboration applies Syrrx's expertise in high-throughput crystallization of proteins across multiple Biogen Idec drug targets.
comments powered by